Bernstein reiterates Outperform on Zydus Lifesciences, targets ₹1,457
Zydus Lifesciences shares rose nearly 3% on Sept. 18 after Bernstein maintained an "Outperform" rating and set a target price of ₹1,457.
Shares of Zydus Lifesciences rose nearly 3% on Friday, September 18, after Bernstein kept its "Outperform" rating on the stock and set a target price of ₹1,457 per share. The target is the highest among analysts covering the drugmaker and implies upside of more than 28…